L. Lahousse (Ghent, Belgium), J. Nieto-Fontarigo (Santiago De Compostela, Spain)
Late Breaking Abstract - BENRALIZUMAB IN SEVERE ASTHMA: PRELIMINARY RESULTS FROM THE ITALIAN ANANKE STUDY
M. D'Amato (Napoli, Italy), P. Bracciale (Ostunipoli, Italy), E. Altieri (Garbagnate Milanese, Italy), M. Caiaffa (Foggia, Italy), F. De Michele (Napoli, Italy), M. Romagnoli (Treviso, Italy), E. Ansaldo (Basiglio, Italy), G. Canonica (Rozzano, Italy), G. Pelaia (Catanzaro, Italy)
|   |
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
J. Upham (Brisbane , Australia), C. Le Lievre (Singapore, Singapore), D. Jackson (London, United Kingdom), M. Masoli (Plymouth, United Kingdom), M. Wechsler (Denver, United States of America), D. Price (Singapore, Singapore)
| |
Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.
O. Efthymiadou (London, United Kingdom), B. Kamphuis (London, United Kingdom), V. Tzouma (London, United Kingdom), P. Kanavos (London, United Kingdom)
| |
Real life benralizumab effect in patients with severe eosinophilic asthma after 16 weeks of observation
E. Graziani (Roma, Italy), A. Sanna (Roma, Italy), P. Scarano (Roma, Italy), I. Menichini (Roma, Italy), C. Cisternino (Roma, Italy), R. Flore (Roma, Italy), C. Tomsa (Roma, Italy), P. Palange (Roma, Italy)
| |
Does use of hormonal contraceptives impact on exacerbations and control in reproductive-age women with asthma? A 17-year population-based cohort study
S. Shah (Edinburgh, United Kingdom), H. Tibble (Edinburgh, United Kingdom), R. Pillinger (Edinburgh, United Kingdom), S. Mclean (Edinburgh, United Kingdom), D. Ryan (Edinburgh, United Kingdom), H. Critchley (Edinburgh, United Kingdom), D. Price (Aberdeen, United Kingdom), C. Hawrylowicz (London, United Kingdom), C. Simpson (Wellington, New Zealand), I. Soyiri (Hull, United Kingdom), F. Appiagyei (Cambridge, United Kingdom), A. Sheikh (Edinburgh, United Kingdom), B. Nwaru (Gothenburg, Sweden)
| |
Inter-rater reliability of a novel algorithm to calculate Global Initiative for Asthma (GINA) treatment steps
K. Andreasson (Naestved, Denmark), T. Andreasson (Naestved, Denmark), C. Ulrik (Hvidovre, Denmark), K. Sidenius (Elsinore, Denmark), S. Skou (Slagelse, Denmark), M. Thomas (Southampton , United Kingdom), U. Bodtger (Naestved, Denmark)
| |
DETERMINE THE OPTIMAL TIME TO ASSESS THE REVERSIBILITY OF THE LIMITATION TO AIRFLOW
A. Perez Figuera (Madrid, Spain), D. Velasco (Madrid, Spain), R. Morillo (Madrid, Spain), A. Solier (Madrid, Spain), C. Almonacid (Madrid, Spain)
| |
Effect of ABPA treatment in severe asthma patients with acute and relapsed disease
C. Bucca (Torino (TO), Italy), L. Brussino (Torino (TO), Italy), I. Ridolfi (Torino (TO), Italy), F. De Blasio (Torino (TO), Italy), S. Nicola (Torino (TO), Italy), G. Rolla (Torino (TO), Italy)
| |
Patient preferences for asthma management: a qualitative study
C. Baggott (Wellington, New Zealand), A. Chan (Auckland, New Zealand), S. Hurford (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand), R. Beasley (Wellington, New Zealand), M. Harwood (Auckland, New Zealand), H. Reddel (Sydney, Australia), W. Levack (Wellington, New Zealand)
| |
Influence of asthma treatment during pregnancy on fetal biometry.
M. Barca Hernando (Seville, Spain), D. Ramos Apoyala (Seville, Spain), M. Romero Falcón (Seville, Spain), J. Gallardo Medina (Seville, Spain), F. Álvarez Gutiérrez (Seville, Spain)
| |
SNPs in asthma patients: gender difference in anti-leukotriene therapy
G. Spaziano (Napoli (NA), Italy), R. Esposito (Napoli (NA), Italy), D. Mirra (Napoli (NA), Italy), E. Piegari (Napoli (NA), Italy), A. Rossi (Napoli (NA), Italy), F. Roviezzo (Napoli (NA), Italy), L. Gallelli (Catanzaro, Italy), L. Berrino (Napoli (NA), Italy), B. D'Agostino (Napoli (NA), Italy)
| |
THE IMPACT OF REFLEXOLOGY AND HOMEOPATHY ADDED TO CONVENTIONAL ASTHMA TREATMENT ON MARKERS OF AIRWAY INFLAMMATION– A RANDOMISED STUDY
A. Topcu (Horsens, Denmark), A. Løkke Ottesen (Vejle, Denmark), L. Eriksen (Copenhagen, Denmark), L. Peter Nielsen (Aarhus, Denmark), R. Dahl (Copenhagen, Denmark)
| |
Bronchial thermoplasty in Thailand: 3-year experience in real-world practice
V. Thanthitaweewat (Bangkok, Thailand), N. Leelayuwatanakul (Bangkok, Thailand), T. Sriprasart (Bangkok, Thailand)
| |
Study to evaluate clinical burden related with oral corticosteroids treatment of severe asthma in Spain (LEVANTE)
X. Muñoz Gall (Barcelona, Spain), J. Dominguez Ortega (Madrid, Spain), S. Pascual Erquicia (Bilbao, Spain), C. Cabrera Lopez (Las Palmas de Gran Canaria, Spain), C. Martin Panadero (Madrid, Spain), G. Monteagudo Ruiz (Madrid, Spain), G. Resler (Madrid, Spain)
| |
Prescribing Trends of Oral Corticosteroids Among Young Adults with Active Asthma
I. Skov (Odense, Denmark), D. Henriksen (Odense, Denmark), A. Pottegård (Odense, Denmark), H. Madsen (Odense, Denmark), J. Davidsen (Odense, Denmark)
| |
Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma
A. Vianello (Padua (PD), Italy), G. Guarnieri (Padua (PD), Italy), B. Molena (Padua (PD), Italy), N. Malacchini (Padua (PD), Italy), F. Chieco Bianchi (Padua (PD), Italy), I. Ferrarotti (Pavia (PV), Italy), M. Caminati (Verona (VR), Italy), G. Senna (Verona (VR), Italy)
| |
Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations
. Dayal (South San Francisco, United States of America), D. Cheung (South San Francisco, United States of America), C. Iribarren (Oakland, United States of America), M. Rothenberg (South San Francisco, United States of America), Y. Ding (Hoboken, United States of America), C. Spain (South San Francisco, United States of America)
| |
The profile of poor ICS adherence in uncontrolled moderate to severe asthma.
L. Keulers (LEEUWARDEN, Netherlands), K. De Jong (LEEUWARDEN, Netherlands), A. Ten Brinke (LEEUWARDEN, Netherlands), A. Van Der Meer (LEEUWARDEN, Netherlands)
| |
Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
A. Kiani (Tehran, Islamic Republic of Iran), F. Razavi (Tehran, Islamic Republic of Iran), M. Farahani (Tehran, Islamic Republic of Iran), N. Bandegani (Tehran, Islamic Republic of Iran), J. Valizadeh (Tehran, Islamic Republic of Iran), H. Emami (Tehran, Islamic Republic of Iran), A. Abedini (Tehran, Islamic Republic of Iran)
| |
Systematic review of the comparison between adrenaline (epinephrine) and selective ß2-agonist in the setting of adults or children with acute asthma
C. Baggott (Wellington, New Zealand), J. Hardy (Wellington, New Zealand), J. Sparks (Wellington, New Zealand), D. Sabbagh (Wellington, New Zealand), R. Beasley (Wellington, New Zealand), M. Weatherall (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand)
| |